Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Levosalbutamol (0.5mg/5ml) + Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) Syrup
Therapeutic Category
Pediatrics, Respiratory, Asthma, Cold and Cough
Dosage Form
Syrup
Packaging Type
Bottle
Packaging
60ml
Price
₹88/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cufsniff LS Junior Syrup contains a combination of Levosalbutamol (0.5 mg/5 ml), Ambroxol (15 mg/5 ml), and Guaifenesin (50 mg/5 ml). Levosalbutamol is a bronchodilator that relaxes the airway muscles for easier breathing, Ambroxol is a mucolytic that breaks down thick mucus, and Guaifenesin is an expectorant that helps clear mucus from the respiratory tract.
It helps in the treatment of productive cough, bronchitis, and other respiratory tract infections by easing breathing and clearing airway congestion in children.
May cause mild nausea, vomiting, dry mouth, dizziness, or restlessness. Rarely, allergic reactions or palpitations may occur.
Indicated for children suffering from wet cough, bronchial congestion, asthma-related symptoms, or respiratory infections. Use under pediatric supervision.
Use only as prescribed by a pediatrician. Shake well before use. Monitor for side effects and inform your doctor of any ongoing medical treatments.
Store below 25°C in a cool, dry place, protected from sunlight. Keep out of reach of children. Use within the recommended duration after opening.
Composition : Chlorpheniramine Maleate (2mg) + Paracetamol (250mg) + Phenylephrine (5mg)
Composition : Deflazacort (6mg/5ml)
Composition : Fexofenadine (30mg/5ml)
Composition : Hydroxyzine (10mg) Syrup
Composition : Ibuprofen (100mg) + Paracetamol (125mg)
Composition : Levofloxacin (125mg/5ml) + Ornidazole (125mg/5ml)
Composition : Ofloxacin (50mg) + Metronidazole (120mg) + Simethicone (10mg)
Composition : Ofloxacin (50mg/5ml)
Composition : Ondansetron (2mg)
Composition : Paracetamol (250mg/5ml)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination syrup is used for productive cough, bronchial asthma, COPD, chest congestion, and respiratory tract infections. It combines a bronchodilator (levosalbutamol), mucolytic (ambroxol), and expectorant (guaifenesin), making it a strong respiratory segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from strong seasonal demand during winter and monsoon respiratory infection seasons. It is widely prescribed by general physicians, pediatricians, and pulmonologists for wet cough with mucus and wheezing, ensuring steady pharmacy sales and repeat demand.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for respiratory formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high prescription volume, pediatric and adult usage, seasonal demand peaks, and consistent repeat purchases in respiratory care segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this respiratory formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.